While numerous reports suggest that expression of CGB genes may be valuable cancer biomarkers and prognostic factors, the extent to which each CGB gene is expressed in diverse cancers has not yet been systematically evaluated using the large cohorts of cancer patients available today. The gene discussed is CGB3; the disease is cancer.